StockData
BIO-TECHNE Corp logo

BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/3040% above fair value
$72.80−0.02 (-0.03%)

Close on Nov 11, 2026Market cap $11.43BP/E 66.8Yield 0.44%

Bio-Techne profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Bio-Techne's profit margin for the twelve months ending Mar 31, 2026 was 9.0%. For fiscal 2025 it was 6.0%, against 14.5% the year before. The highest annual figure on record is 40.8% in fiscal 2010.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Jun 30, 20256.0%−8.5
FY2024Jun 30, 202414.5%−10.6
FY2023Jun 30, 202325.1%+0.5
FY2022Jun 30, 202224.6%+9.5
FY2021Jun 30, 202115.1%−16.0
FY2020Jun 30, 202031.0%+17.6
FY2019Jun 30, 201913.5%−6.2
FY2018Jun 30, 201819.6%+6.1
FY2017Jun 30, 201713.5%−7.4
FY2016Jun 30, 201620.9%−2.9
FY2015Jun 30, 201523.8%−7.2
FY2014Jun 30, 201431.0%−5.2
FY2013Jun 30, 201336.2%+0.5
FY2012Jun 30, 201235.7%−3.0
FY2011Jun 30, 201138.7%−2.1
FY2010Jun 30, 201040.8%+0.9
FY2009Jun 30, 200939.9%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Sep 30, 20269.4%+15.0
Q3 FY2026CQ1 2026Mar 31, 202616.4%+9.2
Q2 FY2026CQ4 2025Dec 31, 202512.8%+1.1
Q1 FY2026CQ3 2025Sep 30, 202513.3%+1.7
Q4 FY2025CQ2 2025Jun 30, 2025-5.6%−18.8
Q3 FY2025CQ1 2025Mar 31, 20257.1%−9.0
Q2 FY2025CQ4 2024Dec 31, 202411.7%+1.7
Q1 FY2025CQ3 2024Sep 30, 202411.6%−6.8
Q4 FY2024CQ2 2024Jun 30, 202413.3%−11.8
Q3 FY2024CQ1 2024Mar 31, 202416.2%−7.7
Q2 FY2024CQ4 2023Dec 31, 202310.1%−8.3
Q1 FY2024CQ3 2023Sep 30, 202318.4%−14.8
Q4 FY2023CQ2 2023Jun 30, 202325.1%+3.7
Q3 FY2023CQ1 2023Mar 31, 202323.9%+3.0
Q2 FY2023CQ4 2022Dec 31, 202218.4%−11.4
Q1 FY2023CQ3 2022Sep 30, 202233.2%+6.2
Q4 FY2022CQ2 2022Jun 30, 202221.3%+15.6
Q3 FY2022CQ1 2022Mar 31, 202220.9%+2.1
Q2 FY2022CQ4 2021Dec 31, 202129.8%+9.1
Q1 FY2022CQ3 2021Sep 30, 202127.0%+10.7
Q4 FY2021CQ2 2021Jun 30, 20215.8%−27.7
Q3 FY2021CQ1 2021Mar 31, 202118.8%+0.1
Q2 FY2021CQ4 2020Dec 31, 202020.6%−44.0
Q1 FY2021CQ3 2020Sep 30, 202016.4%+8.5
Q4 FY2020CQ2 2020Jun 30, 202033.5%+24.9
Q3 FY2020CQ1 2020Mar 31, 202018.7%−5.4
Q2 FY2020CQ4 2019Dec 31, 201964.7%+54.6
Q1 FY2020CQ3 2019Sep 30, 20197.9%−2.8
Q4 FY2019CQ2 2019Jun 30, 20198.6%−14.5
Q3 FY2019CQ1 2019Mar 31, 201924.2%+12.1
Q2 FY2019CQ4 2018Dec 31, 201810.1%−21.6
Q1 FY2019CQ3 2018Sep 30, 201810.7%−0.3
Q4 FY2018CQ2 2018Jun 30, 201823.1%+5.5
Q3 FY2018CQ1 2018Mar 31, 201812.0%−3.4
Q2 FY2018CQ4 2017Dec 31, 201731.7%+26.0
Q1 FY2018CQ3 2017Sep 30, 201711.0%–
Q4 FY2017CQ2 2017Jun 30, 201717.6%–
Q3 FY2017CQ1 2017Mar 31, 201715.4%–
Q2 FY2017CQ4 2016Dec 31, 20165.7%–

More Bio-Techne figures

See a number that looks wrong?